Disease Areas
Pathnostics UTI Test Nabs New York State Approval
The molecular test identifies organisms and resistance genes combined with pooled antibiotic susceptibility results.
FDA Approves Entrogen's RAS Mutation Detection Kit as CDx for Vectibix
The test, intended for use with Amgen's Vectibix, detects KRAS and NRAS exon 2, 3, and 4 mutations in colorectal cancer patients.
ProciseDx Gets US Marketing Clearance for Infliximab, Adalimumab POC Monitoring Tests
The firm plans this year to launch in the US its tests used to measure drug levels in inflammatory bowel disease patients and guide treatment.
Genomic Health to Pay $32.5M to Resolve Cancer Test False Claims Allegations by DOJ
The settlement includes the resolution of allegations brought in two separate actions filed against the firm under the whistleblower provisions of the False Claims Act.
Vela Diagnostics Inks Japan Distribution Agreement for HIV-1 Drug Resistance Tests
Singapore-based Vela said the deal will aid sales of its next-generation sequencing-based test for use in treatment and monitoring of HIV-1 infection.
Sep 29, 2023
Sep 27, 2023
Sep 26, 2023
Sep 25, 2023
Sep 21, 2023